Migdal Insurance & Financial Holdings »

Cytokinetics shares owned by Migdal Insurance & Financial Holdings

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Migdal Insurance & Financial Holdings from 13F filings

Historical chart of Migdal Insurance & Financial Holdings investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Migdal Insurance & Financial Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Migdal Insurance & Financial Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 284 63.38

More positions owned by Migdal Insurance & Financial Holdings

Teva Pharmaceutical-sp Adr (TEVA)
Invesco Nasdaq 100 Etf Etp (QQQM)
Ss Technology Select Sector Etp (XLK)
Ss Industrial Select Sector Etp (XLI)
Nova Common Stock (NVMI)
Alphabet Inc-cl C Common Stock (GOOG)
St Sr Utl Sl Se Spdr Etf-usd Etp (XLU)
Amazon.com Common Stock (AMZN)
Taiwan Semiconductor-sp Adr (TSM)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Tower Semiconductor Common Stock (TSEM)
Ss Consumer Disc Select Sect Etp (XLY)
Ss Comm Select Sector Spdr Etp (XLC)
Ishares Expanded Tech-softwa Etp (IGV)

View all positions for Migdal Insurance & Financial Holdings

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics